Biologic differences between peripheral and transition zone prostate cancer

June 2017

Cancer

Country of origin: USA

Prostate cancer arises in the transition zone (TZ) in approximately 20–25% of cases. Modern biopsy and surveillance protocols, and advances in prostate cancer imaging, have renewed interest in TZ prostate cancers. We compared TZ and PZ prostate cancer to determine if cancer location is independently associated with better outcomes.

METHODS
We evaluated an expanded cohort of 1354 men who underwent radical prostatectomy between 1983 and 2003 with updated long-term clinical follow-up. Regression models were used to compare the volume of high-grade (Gleason 4 or 5) cancer and total cancer volume by location. Uni- and multi-variable logistic regression models tested the associations between cancer location and adverse pathologic features. Multivariable proportional hazard models were fit to examine cancer recurrence.

RESULTS
Patients with TZ cancer presented with higher pre-operative serum PSA values (11.07 vs. 7.86 ng/ml) and larger total cancer volume (7.1 vs. 3.8 cc). Patients with TZ cancer had decreased odds of seminal vesicle invasion (OR 0.08, 95% CI 0.03, 0.21), extra-capsular extension (OR 0.56, 95% CI 0.35, 0.92), and lymphovascular invasion (OR 0.48, 95% CI 0.27, 0.87) in multivariable models. TZ cancers were independently associated with decreased hazard of tumor recurrence (HR 0.62, 95% CI 0.43, 0.90).

CONCLUSIONS
TZ cancer prostate is associated with favorable pathologic features and better recurrence-free survival despite being diagnosed with larger cancers and higher PSA values. Tumor location should be taken into account when stratifying patient risk before and after prostatectomy, particularly with the evolving role of imaging in prostate cancer management. Prostate 75:183–190, 2015. © 2014 Wiley Periodicals, Inc.

Resources

inPractice® Oncology June 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Cancer Research Network Measures March 2018 Following a period of consultation Cancer Research Network Measures have been issued by the Department of Health as part of...
Orlive Surgical Broadcasts February 2018 Orlive is a trusted world resource in surgical broadcasting for physians, surgeons and caregivers.
ONCO Assist January 2018 Oncoassist app was designed by oncologists keeping in mind the clinical needs that arise while treating cancer patients....
Cancer.net mobile by ASCO January 2018 The Cancer.net mobile app by ASCO provides info on 120 types of cancer, including treatment information, managing side...
Chemo Calendar January 2018 Chemo Calendar app by Health Monitor Network can track the patient’s symptoms. It captures key symptoms like temperature,...
Cancer Navigator January 2018 Cancer Navigator app was developed by MD Acuity, LLC. The app tracks symptoms during cancer treatment in a graphic...
Oncology Nurse Advisor January 2018 Oncology Nurse Advisor is a free, simple to use, medical app that offers oncology nurses the latest news and trends....
Breast Cancer Survivor January 2018 Survivorship encompasses a range of lifestyle approaches to improve wellbeing and survival after a diagnosis of cancer....
Cancer Emergency Response Tool January 2018 The Cancer Emergency Response Tool (CERT) allows cancer patients to rapidly and effectively manage chemotherapy toxicity...
Search by Keyword